UNSPSC 85693573: Supplement left clavicle with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left clavicle with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0PUB3KZ

UNSPSC 85693573 Supplement left clavicle with nonautologous tissue substitute, percutaneous approach is a Commodity code that shows little relevant recent activity. The code's nominal scope describes a specific orthopedic surgical procedure, yet the recent state and local opportunities posted under this code are instead soliciting independent medical evaluation services, pharmacy benefit management, occupational health surveillance, specialty surgical carve-out networks, emergency detention healthcare, and temporary health professional staffing—none of which align with procurement of clavicle implants or orthopedic surgical supplies. The mismatch between the code's stated commodity and the work actually being bought suggests misclassification in the originating procurement systems rather than genuine market activity for the implant itself.

The six opportunities spanning August through September 2026 originate across diverse issuing bodies: the City of Phoenix Retirement Office, the City of Long Beach, the Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County Board of County Commissioners, and the County of Santa Clara Health System. Geographic activity is concentrated in three states—Arizona, California, and Washington—with a fourth across Texas. Because the recent opportunities do not reflect procurement aligned with the Commodity code's description, no representative examples of actual clavicle implant or related orthopedic surgical product solicitation can be drawn from the source.